Antimicrobial activity and SAR study of some novel thiosemicarbazide derivatives bearing piperidine moiety

Medicinal Chemistry

Volumn 7, Issue 6, 2011, Pages 690-696

  Siwek, Agata ^a   Stefańskab, Joanna ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antibacterial activity; Antifungal activity; Conformational analysis; Physicochemical descriptors; Piperidine derivatives; Thiosemicarbazide derivatives

Indexed keywords

CIPROFLOXACIN; FLUCONAZOLE; PIPERIDINE DERIVATIVE; THIOSEMICARBAZIDE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; DRUG CONFORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 80755143184     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340611797928406     Document Type: Article

References (31)

1. Thompson, L.A.; Ellman, J.A. Synthesis and applications of small molecules libraries. Chem. Rev. 1996, 96, 555-600. (Pubitemid 126637733)
2. Robert, G.F. Recent advances in the preparation of heterocycles on solid support: A review of the literature. J. Comb. Chem., 2000, 2, 195-214.
3. Zhao, D.; Yushe, Y.; Ruyun, J.; Shuhua, Z. Synthesis and antibacterial activity of novel fluoroquinolones containing substituted piperidines. Bioorg. Med. Chem. Lett., 2007, 17, 4523-4526.
4. Xiaoguang, H.; Aiqin, Z.; Dongliang, C.; Zhenhua, J.; Xingshu, L. 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: Novel C7 moieties of fluoroquinolones as antibacterial agents. Bioorg. Med. Chem. Lett., 2010, 20, 2859-2863.
5. Yun, C.; Mingliang, L.; Bo, W.; Xuefu, Y.; Lianshun, F.; Yibin, Z.; Jue, C.; Huiyuan, G. Synthesis and in vitro antibacterial activity of novel fluoroquinolone derivatives containing substituted piperidines. Bioorg. Med. Chem. Lett., 2010, 20, 5195-5198.
6. Gottler, L.M.; Ramamoorthy, A. Structure, membrane orientation, mechanism, and function of pexiganan-A highly potent antimicrobial peptide designed from magainin. BBA Biomembranes, 2009, 1788, 1680-1686.
7. Marsh, E.N.G.; Buer, B.C.; Ramamoorthy A. Fluorine-a new element in the design of membrane-active peptides. Mol. BioSyst., 2009, 5, 1143-1147.
8. Wade, D.; Andreu, D.; Mitchell, S.A.; Silveira, A.M.V.; Boman, A.; Boman, H.G.; Merrifield, R.B. Antibacterial peptides designed as analogs or hybrids of cecropins and melittin. Int. J. Pept. Protein Res., 1992, 40, 429-436.
9. Suhas, R.; Chandrashekar, S.; Gowda, D.Ch. Synthesis of elastin based peptides conjugated to benzisoxazole as a new class of potent antimicrobials-A novel approach to enhance biocompatibility. Eur. J. Med. Chem., 2011, 46, 704-711.
10. Higashibayashi, S.; Hashimoto, K.; Nakata, M. Synthetic studies on the thiostrepton family of peptide antibiotics: Synthesis of the tetrasubstituted dehydropiperidine and piperidine cores. Tetrahedron Lett., 2002, 43, 105-110. (Pubitemid 34008538)
11. Alexidis, A.N.; Commandeur, J.N.M.; Rekka, E.A.; Groot, E.; Kourounakis, P.N.; Vermeulen, N.P.E. Novel piperidine derivatives: Inhibitory properties towards cytochrome P450 isoforms, and cytoprotective and cytotoxic characteristic. Environ. Toxicol. Pharm., 1996, 1, 81-88. (Pubitemid 26091992)
12. Sun, Q.-Y.; Xu, J.-M.; Cao, Y.-B.; Zhang, W.-N.; Wu, Q.-Y.; Zhang, D.-Z.; Zhang, J.; Zhao, H.-Q.; Jiang, Y.-Y. Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14-demethylase (CYP51). Eur. J. Med. Chem., 2007, 42, 1226-1233. (Pubitemid 47238543)
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disc susceptibility tests; approved standard M2-A9. Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2006.
14. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2006.
15. Dobosz, M.; Siwek, A.; Chodkowska, A.; Jagieo-Wójtowicz, E. Synthesis and some pharmacological properties of 3-(piperidin-4-yl)-4- substituted-2-1,2,4-triazoline-5-thione. Acta Polon. Pharm., 2004, 61, Supplement, 5-7.
16. Kosikowska, U.; Siwek, A.; Dobosz, M. Antimicrobial activities of 4-substituted-3-(piperidin-4-yl)-4,5-dihydro-1H-1,2,4-triazole-5-thiones. Acta Polon. Pharm., 2006, 63, 460-463.
17. Ezabadi, I.R.; Camoutsis, C.; Zoumpoulakis, P.; Geronikaki, A.; Sokovi, M.; Glamoilija, J. Sulfonamide-1,2,4-triazole derivatives as antifungal and antibacterial agents: Synthesis, biological evaluation, lipophilicity, and conformational studies. Bioorg. Med. Chem., 2008, 16, 1150-1161. (Pubitemid 351193036)
18. KuŞgon, C.; Ayhan-Kilcigil, G.; Özbey, S.; Kaynak, F.B.; Kaya, M.; Sçoban, T.; Can-Eke, B. Synthesis and antioxidant properties of novel N-methyl-1,3,4-thiadiazol-2-amine and 4-methyl-2H-1,2,4-triazole-3-(4H)- thione derivatives of benzimidazole class. Bioorg. Med. Chem., 2008, 16, 4294-4303. (Pubitemid 351539047)
19. Önkol, T.; Dǒruer, D.S.; Uzun, L.; Adak, S.; Özkan, S.; Şgon, M.F.J. Synthesis and antimicrobial activity of new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. J. Enzym. Inhib. Med. Chem., 2008, 23, 277-284.
20. Shams, H.Z.; Mohareb, R.M.; Helal, M.H.; Mahmoud, A.E. Synthesis, structure elucidation, and biological evaluation of some fused and/or pendant thiophene, pyrazole, imidazole, thiazole, triazole, triazine, and coumarin systems based on cyanoacetic 2-[(benzoylamino)thioxomethyl] hydrazide. Phosphorus Sulfur Silicon Relat. Elem., 2007, 182, 237-263.
21. Bryskier, A.; Chantot, J.F. Classification and structure-activity relationships of fluoroquinolones. Drugs, 1995, 49, 16-28.
22. Forroumadi, A.; Emami, S.; Mehni, M.; Moshafi, M. H.; Shafiee, A. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones. Bioorg. Med. Chem. Lett., 2005, 15, 4536-4539. (Pubitemid 41253889)
23. Kozminykh, E.N.; Goncharov, V.I.; Kozminykh, V.O. Molecularbiological problems of drug design and mechanism of drug action. Pharm. Chem. J., 2008, 42, 513-519.
24. Al-Qawasmeh, A.R.A.; Huesca, M.; Nedunuri, V.; Peralta, R.; Wright, J.; Lee, Y.; Young, A. Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2- yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus. Bioorg. Med. Chem. Lett., 2010, 20, 3518-3520.
25. Güven, Ö.Ö.; Taner, E.; Hakan, G.; Sulhiye, Y. Synthesis and antimicrobial activity of some novel phenyl and benzimidazole substituted benzyl ethers. Bioorg. Med. Chem. Lett. 2007, 17, 2233-2236. (Pubitemid 46505260)
26. GÖker, H.; Tunçbilek, M.; Ayhan, G.; Altanlar, N. Synthesis of some new benzimidazolecarboxamides and evaluation of their antimicrobial activity. Il Farmaco, 1998, 53, 415-420. (Pubitemid 28408767)
27. Özden, S.; Atabey, D.; Yildiz, S.; GÖker, H. Synthesis and potent antimicrobial activity of some novel methyl or ethyl 1Hbenzimidazole-5- carboxylates derivatives carrying amide or amidine groups. Bioorg. Med. Chem., 2005, 13, 1587-1597. (Pubitemid 40215246)
28. Cornell, W.D.; Cieplak, P.; Bayly, C.I.; Gould, I.R.; Merz Jr, K.M.; Ferguson, D.M.; Spellmeyer, D.C.; Fox, T.; Caldwell, I.W.; Kollman, P.A. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc., 1995, 117, 5179-5197.
29. MacKerell, A.D.; Bashford, D.; Bellott, M.; Dunbrack, R.L.; Evanseck, J.D.; Field, M.J.; Fischer, S.; Gao, J.; Guo, H.; Ha, S.; Joseph-McCarthy, D.; Kuchnir, L.; Kuczera, K.; Lau, F.T.K.; Mattos, C.; Michnick, S.; Ngo, T.; Nguyen, D.T.; Prodhom, B.; Reiher, W.E.; Roux, B.; Schlenkrich, M.; Smith, J.C.; Stote, R.; Straub, J.; Watanabe, M.; Wiorkiewicz-Kuczera, J.; Yin, D.; Karplus, M. All-atom empirical potential for molecular modeling and dynamic studies of proteins. J. Phys. Chem. B., 1998, 102, 3586-3616. (Pubitemid 128576688)
30. Jorgensen, W.L.; Tirado-Rives, J. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J. Am. Chem. Soc., 1988, 110, 1657-1666.
31. HyperChem 8.0.3, HyperCube Inc., Gainsville, FL, USA, 2007.